PMC:7396557 / 45866-46025 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T340","span":{"begin":101,"end":106},"obj":"UBERON:0001988"},{"id":"T341","span":{"begin":131,"end":137},"obj":"UBERON:0001988"},{"id":"T3835","span":{"begin":101,"end":106},"obj":"UBERON:0001988"},{"id":"T91838","span":{"begin":131,"end":137},"obj":"UBERON:0001988"}],"text":"4) It contains rheum, so the dose should be reduced appropriate in subjects who experience increased stool frequency and shapeless stools after administration."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T258","span":{"begin":101,"end":106},"obj":"Body_part"},{"id":"T259","span":{"begin":131,"end":137},"obj":"Body_part"}],"attributes":[{"id":"A258","pred":"fma_id","subj":"T258","obj":"http://purl.org/sig/ont/fma/fma64183"},{"id":"A259","pred":"fma_id","subj":"T259","obj":"http://purl.org/sig/ont/fma/fma64183"}],"text":"4) It contains rheum, so the dose should be reduced appropriate in subjects who experience increased stool frequency and shapeless stools after administration."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T116","span":{"begin":101,"end":106},"obj":"Body_part"},{"id":"T117","span":{"begin":131,"end":137},"obj":"Body_part"}],"attributes":[{"id":"A116","pred":"uberon_id","subj":"T116","obj":"http://purl.obolibrary.org/obo/UBERON_0001988"},{"id":"A117","pred":"uberon_id","subj":"T117","obj":"http://purl.obolibrary.org/obo/UBERON_0001988"}],"text":"4) It contains rheum, so the dose should be reduced appropriate in subjects who experience increased stool frequency and shapeless stools after administration."}

{"project":"LitCovid-sentences","denotations":[{"id":"T340","span":{"begin":0,"end":159},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"4) It contains rheum, so the dose should be reduced appropriate in subjects who experience increased stool frequency and shapeless stools after administration."}